Consensus ADMA Biologics, Inc.

Equities

ADMA

US0008991046

Real-time Estimate Cboe BZX 01:13:14 2024-04-29 pm EDT 5-day change 1st Jan Change
6.585 USD +0.53% Intraday chart for ADMA Biologics, Inc. +6.37% +45.91%

Evolution of the average Target Price on ADMA Biologics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

828.YgqGRD5HNVlQ55bDK3d5Lt5T0lJAuVkgt0nyPTul-78.K03VNFclfmwfqdW5fE4TRIQSphsP-jYV8jiEaHnilI4lTuMnax58CR-__Q~678cb18e2c0c3885e4638c881391e95c
HC Wainwright Adjusts ADMA Biologics Price Target to $7.50 From $6, Maintains Buy Rating MT
Mizuho Adjusts Price Target on ADMA Biologics to $10 From $9, Maintains Buy Rating MT
Mizuho Securities Raises Price Target on ADMA Biologics to $9 From $7, Maintains Buy Rating MT
HC Wainwright Adjusts Price Target on ADMA Biologics to $6 From $5, Maintains Buy Rating MT
Raymond James Adjusts Price Target on ADMA Biologics to $6 From $5, Maintains Strong Buy Rating MT
HC Wainwright Adjusts Price Target on ADMA Biologics to $5 From $4.50, Maintains Buy Rating MT
HC Wainwright Ups Price Target on ADMA Biologics to $4.50 From $4, Keeps Buy Rating MT
Mizuho Securities Adjusts Price Target on ADMA Biologics to $6 From $5, Maintains Buy Rating MT
Mizuho Securities Starts ADMA Biologics at Buy With $5 Price Target MT
HC Wainwright Adjusts ADMA Biologics' Price Target to $4 from $6, Keeps Buy Rating MT
ADMA Biologics Q3 Loss Narrows as Sales Rise; Raymond James Lifts Stock Rating -- Shares Soar Thursday Afternoon MT
Raymond James Upgrades ADMA Biologics to Strong Buy From Outperform; Keeps Price Target at $5 MT
Cantor Fitzgerald Starts ADMA Biologics at Overweight With $4.50 Price Target MT
ADMA BIOLOGICS : Chardan Suspends Coverage on ADMA Biologics at Buy Rating With $11 Price Target MT
ADMA BIOLOGICS : HC Wainwright Adjusts ADMA Biologics' Price Target to $7 From $10, Keeps Buy Rating MT
DJ Industrial : Stocks Fall Ahead of Fed Rate Decision MT
Midday Report: Wall Street Falls Ahead of Fed Rate Decision MT
DJ Industrial : Wall Street Subdued Pre-Open, Fed Rate Decision in Focus MT
ADMA BIOLOGICS : Raymond James Adjusts ADMA Biologics' Price Target to $6 From $7, Maintains Outperform Rating MT
ADMA BIOLOGICS : HC Wainwright Adjusts ADMA Biologics' Price Target to $11 From $12, Keeps at Buy MT
ADMA BIOLOGICS : Oppenheimer Adjusts ADMA Biologics' Price Target to $4 From $6, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
6.55 USD
Average target price
8.375 USD
Spread / Average Target
+27.86%
High Price Target
10 USD
Spread / Highest target
+52.67%
Low Price Target
7.5 USD
Spread / Lowest Target
+14.50%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ADMA Biologics, Inc.

HC Wainwright
Mizuho Securities
Raymond James
Cantor Fitzgerald
Chardan
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
  1. Stock Market
  2. Equities
  3. ADMA Stock
  4. Consensus ADMA Biologics, Inc.